Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer-Reference-Cited by-全球学者库

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

Published:2014-09-25 Issue:9 Volume:9 Page:e103482
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Hao,Liang Xi,Duan Chao,Liu Caigang,Zhao Zuowei

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Educating undergraduate medical students about oncology: a literature review. J Clin Oncol;J Gaffan,2006

2. Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and postneoadjuvant chemotherapy;M Kasami;Breast,2008

3. Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast;A Rody;Oncol Rep,2004

4. Triple-negative breast cancer: risk factors to potential targets;BP Schneider;Clin Cancer Res,2008

5. Arsenic trioxide and breast cancer: Analysis of the apoptotic, differentiative and immunomodulatory effects;G Baj;Breast Cancer Res.,2002

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in Cancer Detection, Diagnosis, and Prognosis;Sensors;2023-12-20

2. Galectin-3’s Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential;Biomolecules;2023-10-10

3. Unveiling the potential of galectin-3 as a diagnostic biomarker for pancreatic cancer: a review;Annals of Medicine & Surgery;2023-10-02

4. Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival;Tumor Biology;2023-08-10

5. Galectin-1-mediated MET/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosis;Aging;2023-07-11